{"name":"Glycadia","slug":"glycadia","ticker":"","exchange":"","domain":"","description":"Glycadia is a biotechnology company focused on developing novel treatments for cancer. The company's lead candidate, GLY-230, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE0wV3IwZFRaMDg1ZjJWT0FSSHZlc1ZLSWRkS0l5MFoza21zdWNQM2tSNUx4bjhlMkRSVVBKeDRXY0xnblZNZmVVQ01uZ0hZOUk5UUtOd0Rac1o5aFo2MGlqRTc0dU9OWU53MVlobE8xNUk?oc=5","date":"2023-03-08","type":"pipeline","source":"MedPage Today","summary":"Early Metformin Cuts Long COVID Risk - MedPage Today","headline":"Early Metformin Cuts Long COVID Risk","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}